Investors
Overview
Overview
Who We Are
Cyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics and mitosis biology. Our strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates that address oncology and hematology indications.
News Releases
Sep 04 2024
Sep 03 2024
Aug 14 2024
Events
Sep
09
2024
at 7:00 AM EDT
Aug
14
2024
at 4:30 PM EDT
Jun
01
2024
at 9:00 AM CDT